CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FiercePharma
Original article

{"a":[{"_":"Baxter issues recall of 2 products after particulate concerns resurface","$":{"href":"/manufacturing/baxter-issues-recall-2-products-over-particulate-matter-vitruvias-recalls-thyroid","hreflang":"en"}}]}

RegulatoryBaxter Product 1Baxter Product 2Vitruvias Thyroid TabletsNegative
AI Analysis

Summary

Baxter has recalled two products due to particulate matter concerns, while Vitruvias Therapeutics recalled one lot of thyroid tablets for being potentially superpotent. Both recalls represent manufacturing and quality control issues.

Outcome Details

Product recalls initiated due to particulate matter concerns (Baxter) and superpotent tablets (Vitruvias)

Importance:5/10
Sentiment:
-0.80
product recallmanufacturingparticulate matterquality controlregulatory issuesafety concern
Related Companies

Read the original article

Published by FiercePharma on August 26, 2026 10:21 AM

Read Original